Conatus Pharmaceuticals Implements Veeva Vault eTMF
To improve visibility, control, and collaboration for its ongoing and planned clinical trials, San Diego-based biotech Conatus Pharmaceuticals selected Veeva Vault eTMF and Veeva Vault QualityDocs – cloud applications for the management of clinical study and quality and development documentation, respectively
San Diego-based biotech Conatus Pharmaceuticals has selected Veeva Vault eTMF and Veeva Vault QualityDocs – cloud applications for the management of clinical study and quality and development documentation, respectively. As Conatus expanded its network of external partners across a growing number of sites worldwide, it sought a paperless solution to reduce costs and provide an efficient way for all parties – including a largely mobile clinical workforce – to access content. Read the full text here.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Optimizing Phase III Oncology Trial Recruitment with Data-Driven Insights
February 3rd 2025A pharmaceutical company aimed to launch a Phase III clinical trial for a new oncology drug, focusing on efficient and effective patient recruitment across diverse regions. They evaluated patient populations by analyzing demographics, social determinants of health, and geography. Investigator profiling included practice details, affiliations, referral networks, and clinical trial experience. The final step involved selecting and extracting target lists for implementation.
